Vitaflo Scandinavia has signed an out-licensing agreement for the distribution and sale of SPC-Flakes and Salovum in 11 countries
Vitaflo International's Technical director, Tony Partington:
"Vitaflo International is very proud and excited to be involved in the AF project. We believe it fits in with our strategy and our expertise extremely well and that our international marketing network and scientific approach is perfect for these products. We look forward to close co-operation with our Swedish partners in exploiting this revolutionary Swedish invention worldwide."
Kenneth Mc Lachlan, CEO Vitaflo International:
"An exiting opportunity for both companies to develop and market a product in such an innovative area."
About AF, SPC and Salovum.
The products are classified as food for special medical purpose. Swedish scientists were the first to discover the Antisecretory protein, Factor AF, an endogenous protein found in all living species, including the human body, regulating the body's secretory and Ion balance. Scientists have found and documented, in a long row of Clinical studies, that people suffering from IBD, Mb Meniere and severe diarrhoea, have low amounts of protein AF. Both Swedish and international studies have shown that SPC-Flakes and Salovum can be used effectively of regulating the level of protein AF to therapeutic levels.
Both SPC and Salovum have shown effect in a number of clinical studies in Sweden and abroad, and are subject to patents all over the world. The patents last until 2014, 2016 respectively, and new patent applications were filed in 2006.
SPC-Flakes is used in the treatment of inflammatory bowel disease (IBD) and Mb Ménières disease causing dizziness. Salovum is effective in the acute treatment of inflammatory and secretory conditions.
SPC-Flakes and Salovum have been sold in Sweden for some years. First by Lantmännen AF - Faktor AB, then by Vitaflo Scandinavia who has had the word wide product rights since July 2008. Vitaflo Scandinavia will market and sell the products in its home-market and search for partners elsewhere.
The agreement with Vitaflo International is valid for a period of four years.
About Vitaflo International:
Vitaflo International is a UK based medical nutrition company specialising in disease specific nutrition. Vitaflo International's products are used for conditions where special nutrition rather than drugs or other invasive treatment can achieve improved outcome. Vitaflo International markets its products world-wide via a series of subsidiaries or specialist distributors and in the 12 years of its existence has rapidly expanded and achieved a prominent position in this market and become a leading innovator.
About Vitaflo:
Vitaflo Scandinavia AB, a fully owned subsidiary of Navamedic ASA, is one of the fastest growing specialty pharmaceutical sales and marketing companies in the Nordic area working in 10 therapy areas.
Vitaflo Scandinavia promotes branded and generic prescription medicines; food for specific medical needs as well as OTC products. Vitaflo Scandinavia has its own marketing presence in Denmark, Finland, Iceland, Sweden, Norway and Holland and will have its products marketed through distributors in another 12 territories during 2009.
For further information, please contact:
Roland Sandström, Executive Chairman, Vitaflo Scandinavia AB
E-mail: roland.sandstrom@vitaflo.net
Office: +46 31 335 11 90
Tina Sandström, Managing Director, Vitaflo Scandinavia AB
E-mail: tina.sandstrom@vitaflo.net
Office: +45 48 22 18 38
Kenneth Mc Lachlan, CEO Vitaflo Int.
E-mail: kenneth.mclachlan@btinternet.com
Office: +44 151 70 99 020
Tony Partington, Technical Director Vitaflo Int.
E-mail: tony@vitaflo.co.uk
Office: +44 151 70 99 020
Bernt-Olav Røttingsnes, CEO/CFO Navamedic ASA
E-mail: bor@navamedic.com
Office: +47 67 11 25 44
Mobile: +47 91 34 70 21